{"publication_id":"ae3d602f-12d6-4ef2-acd8-d49b2bc98cbe","method_note":"Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.","sources":[{"study":"Efficacy comparison of dapagliflozin combined with liraglutide versus monotherapy in obese patients with heart failure","doi":"10.1097/MD.0000000000048123","risk_of_bias":"not appraised in public sidecar","directness":"indirect"},{"study":"Effects of liraglutide vs. lifestyle changes on soluble suppression of tumorigenesis-2 (sST2) and galectin-3 in obese subjects with prediabetes or type 2 diabetes after comparable weight loss","doi":"10.1186/s12933-022-01469-w","risk_of_bias":"some_concerns","directness":"direct"},{"study":"Effect of Liraglutide on Arterial Inflammation Assessed as [ 18 F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial","doi":"10.1161/CIRCIMAGING.120.012174","risk_of_bias":"some_concerns","directness":"direct"},{"study":"Metabolic Benefits vs. Cardiovascular Uncertainty: A Critical Review of GLP-1 Receptor Agonists in Type 1 Diabetes","doi":"10.3390/ijms27093882","risk_of_bias":"not appraised in public sidecar","directness":"review"},{"study":"Assessment of cardiovascular event reduction with SGLT2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes mellitus","doi":"10.6026/973206300213000","risk_of_bias":"not appraised in public sidecar","directness":"indirect"},{"study":"Effects of liraglutide on diastolic function parameters in patients with type 2 diabetes and coronary artery disease: a randomized crossover study","doi":"10.1186/s12933-020-01205-2","risk_of_bias":"some_concerns","directness":"direct"},{"study":"Efficacy and safety of glucagon‐like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials","doi":"10.1111/dom.70298","risk_of_bias":"not appraised in public sidecar","directness":"review"},{"study":"Myocardial deformation links combined liraglutide–empagliflozin therapy with improved cardiovascular and economic outcomes in type 2 diabetes: a 6-year study","doi":"10.1093/ehjimp/qyag080","risk_of_bias":"not appraised in public sidecar","directness":"indirect"},{"study":"Comparative cardiovascular and renal outcomes of Liraglutide versus Dulaglutide in Asian type 2 diabetes patients","doi":"10.1038/s41598-024-79255-9","risk_of_bias":"not appraised in public sidecar","directness":"indirect"},{"study":"Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride","doi":"10.1186/s12933-021-01431-2","risk_of_bias":"some_concerns","directness":"direct"},{"study":"Preventive effect of liraglutide on postoperative delirium in elderly patients undergoing cardiac surgery: protocol for a single-centre, randomised, double-blind, placebo-controlled trial","doi":"10.1136/bmjopen-2025-110759","risk_of_bias":"not appraised in public sidecar","directness":"protocol"},{"study":"Real-world cardiovascular effects of liraglutide: transportability analysis of the LEADER trial","doi":"10.1101/2025.05.12.25327466","risk_of_bias":"some_concerns","directness":"direct"},{"study":"Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.","doi":"10.1097/mjt.0000000000002156","risk_of_bias":"not appraised in public sidecar","directness":"review"},{"study":"Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial","doi":"10.1186/s12933-019-0857-6","risk_of_bias":"some_concerns","directness":"direct"},{"study":"Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease","doi":"10.1161/CIRCULATIONAHA.118.036418","risk_of_bias":"not appraised in public sidecar","directness":"indirect"},{"study":"Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway","doi":"10.1186/s12933-019-0954-6","risk_of_bias":"not appraised in public sidecar","directness":"indirect"},{"study":"Cardiovascular outcomes of liraglutide in patients with type 2 diabetes","doi":"10.1097/MD.0000000000017860","risk_of_bias":"not appraised in public sidecar","directness":"indirect"},{"study":"Liraglutide for weight management: a critical review of the evidence","doi":"10.1002/osp4.84","risk_of_bias":"not appraised in public sidecar","directness":"review"},{"study":"Liraglutide and obesity: a review of the data so far","doi":"10.2147/DDDT.S58459","risk_of_bias":"not appraised in public sidecar","directness":"review"}]}